J. Tokunaga et al., BETAMIPRON REDUCES CISPLATIN NEPHROTOXICITY IN RODENTS WITHOUT MODIFYING ITS ANTILEUKEMIC ACTIVITY IN MICE, Renal failure, 19(3), 1997, pp. 425-438
Protective effects of betamipron (BP, N-benzoyl-beta-alanine), one of
a series of N-acyl amino acids, on cisplatin-induced nephrotoxicity we
re examined. Since the damage observed in the kidney is localized to t
he proximal tubule cells, we investigated the influence of BP on urina
ry enzymes and excreta. Male Wistar rats and ddY mice were injected i.
p. with 6 mg/kg and 16 mg/kg, respectively, of cisplatin combined with
an i.p. 250 mg/kg BP dose. The toxicity of cisplatin as indicated by
body weight gain, blood urea nitrogen, and serum creatinine levels was
significantly (p < 0.05) suppressed by administration of BP after cis
platin treatment. The increase in urinary N-acetyl-beta-D-glucosaminid
ase activity, increase and subsequent decrease in gamma-glutamyl trans
ferase activities, and increase in beta(2)-microglobulin level observe
d after treatment with cisplatin were suppressed by administration of
BP after cisplatin treatment. The combination of cisplatin and BP had
no apparent effect on the efficacy of cisplatin against P388 leukemic
cells in mice.